Jim Tumbrink

Jim Tumbrink is an Analyst at Altium Capital Management LP in New York, NY, where he is responsible for in-depth investment research and analysis supporting the firm's portfolio management strategies. At Altium Capital, he focuses on public and private investments in the healthcare sector, particularly biotechnology and specialty pharmaceuticals, reflecting the firm's specialization in life sciences and growth-oriented assets.

Prior to joining Altium Capital, Jim Tumbrink held a position at Tavio Capital LLC, where he gained experience in equity analysis and investment due diligence within healthcare and related growth industries. His professional background emphasizes work in asset management firms concentrating on healthcare innovation and high-potential therapeutic assets.

Jim Tumbrink brings decades of analytical expertise in health sector investing, leveraging deep market knowledge to identify value in emerging therapeutics and medical technology companies. His contributions include supporting transaction diligence and providing actionable research for long/short investment positions in biopharma and medical innovation. Tumbrink’s industry insight is recognized among institutional investors focused on healthcare capital allocation.